Sixteen Days Undetected: Growth Dynamics and the Case for Pre-Positioned Response Capacity in the 2026 Bundibugyo Virus Disease Outbreak, Democratic Republic of the Congo.
{"title":"Sixteen Days Undetected: Growth Dynamics and the Case for Pre-Positioned Response Capacity in the 2026 Bundibugyo Virus Disease Outbreak, Democratic Republic of the Congo.","authors":"Johan G L Verheyden, Celestin Nzanzu Mudogo","doi":"10.1016/j.ijid.2026.109170","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To estimate early growth rate, back-calculate transmission onset, and characterise the case-fatality trajectory of the 2026 Bundibugyo virus disease (BDBV) outbreak in the Democratic Republic of the Congo, the largest recorded BDBV outbreak to date.</p><p><strong>Design or methods: </strong>We analysed a corrected daily surveillance series (65 observations, 14 May-27 July 2026) using non-linear least-squares regression and a Bayesian Poisson growth model fitted by Markov chain Monte Carlo, with five sensitivity analyses.</p><p><strong>Results: </strong>Early confirmed cases grew at 0.1261 per day (95% CI 0.0885-0.1636), a doubling time of 5.50 days (4.24-7.83), three-fold faster than previous BDBV outbreaks (15-18 days). Bayesian back-calculation placed transmission onset on 19 April 2026 (95% highest-density interval 9-27 April), 16 days before the WHO alert and 25 days before laboratory confirmation. Confirmed case-fatality ratio rose from 12.1% to 44.3%; a higher ratio among suspected than confirmed cases on 21 May (23.6% vs 10.8%; p=0.0080) supported progressive reclassification rather than increasing virulence.</p><p><strong>Conclusions: </strong>Rapid BDBV growth leaves little time for outbreak-triggered mobilisation. Sentinel alerts based on unexplained deaths compatible with viral haemorrhagic fever, with healthcare-worker deaths as a high-priority special case, together with pre-positioned surveillance, diagnostic, and response capacity, could reduce avoidable amplification before confirmation.</p>","PeriodicalId":14006,"journal":{"name":"International Journal of Infectious Diseases","volume":" ","pages":"109170"},"PeriodicalIF":4.6000,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijid.2026.109170","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: To estimate early growth rate, back-calculate transmission onset, and characterise the case-fatality trajectory of the 2026 Bundibugyo virus disease (BDBV) outbreak in the Democratic Republic of the Congo, the largest recorded BDBV outbreak to date.
Design or methods: We analysed a corrected daily surveillance series (65 observations, 14 May-27 July 2026) using non-linear least-squares regression and a Bayesian Poisson growth model fitted by Markov chain Monte Carlo, with five sensitivity analyses.
Results: Early confirmed cases grew at 0.1261 per day (95% CI 0.0885-0.1636), a doubling time of 5.50 days (4.24-7.83), three-fold faster than previous BDBV outbreaks (15-18 days). Bayesian back-calculation placed transmission onset on 19 April 2026 (95% highest-density interval 9-27 April), 16 days before the WHO alert and 25 days before laboratory confirmation. Confirmed case-fatality ratio rose from 12.1% to 44.3%; a higher ratio among suspected than confirmed cases on 21 May (23.6% vs 10.8%; p=0.0080) supported progressive reclassification rather than increasing virulence.
Conclusions: Rapid BDBV growth leaves little time for outbreak-triggered mobilisation. Sentinel alerts based on unexplained deaths compatible with viral haemorrhagic fever, with healthcare-worker deaths as a high-priority special case, together with pre-positioned surveillance, diagnostic, and response capacity, could reduce avoidable amplification before confirmation.
期刊介绍:
International Journal of Infectious Diseases (IJID)
Publisher: International Society for Infectious Diseases
Publication Frequency: Monthly
Type: Peer-reviewed, Open Access
Scope:
Publishes original clinical and laboratory-based research.
Reports clinical trials, reviews, and some case reports.
Focuses on epidemiology, clinical diagnosis, treatment, and control of infectious diseases.
Emphasizes diseases common in under-resourced countries.